It is a therapeutic monoclonal antibody that binds to the juxtamembrane region of human epidermal growth factor receptor-2 (HER2) and is successfully used in patients suffering from HER2-overexpressing breast cancer [22]. The gene discussed is ERBB2; the disease is breast cancer.